Cell Free Protein Expression Market Growth Bolstered by Rise in Pharmaceutical R&D and Personalized Medicine Trend

DUBLIN, Nov. 3, 2023 /PRNewswire/ — The “Cell Free Protein Expression – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering.

The report provides an in-depth analysis of the global Cell Free Protein Expression market, forecasting its growth to reach $348.2 million by 2030 from $216.2 million in 2022, at a Compound Annual Growth Rate (CAGR) of 6.1% over the period 2022-2030. Among the segments analyzed, the Protein-Protein Interaction segment is projected to record a 6.7% CAGR and reach $181.1 million by the end of the analysis period. The Protein Labeling segment is estimated to grow at a CAGR of 5.4% over the next 8 years.

Regionally, the U.S. market is estimated at $110.3 million in 2022, while China’s market is forecasted to grow at a 7.9% CAGR over the analysis period 2022 to 2030, reaching a projected market size of $35.3 million by 2030. Other notable geographic markets include Japan and Canada, each forecast to grow at 5% and 5.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.2% CAGR.

The report also includes a competitive landscape analysis featuring 34 key market players such as Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., MilliporeSigma, and others. Furthermore, the report contains special discussions on the global economic climate and market sentiment, coverage on global competitiveness and market presence analysis across multiple geographies.

The report underscores the advantages of Cell Free Protein Expression over traditional methods, its applications, technological advancements, and the growing demand from biotechnology firms and pharmaceutical companies. Factors such as the rising incidence of cancer, increasing demand for personalized medicine, and the growing geriatric population, which is associated with a rise in chronic diseases, are highlighted as drivers for market growth.

GLOBAL MARKET OVERVIEW AND PROSPECTS

Global Market for Cell-free Protein Expression Set to Witness Rapid Growth
Protein-Protein Interactions: Major Market Segment
E. coli lysates: Most Commonly Used Lysate Systems
Mammalian Systems: A Focal Area of Interest
Select Available Mammalian Protein Expression Systems
US Dominates the Cell-free Protein Identification Market

MARKET TRENDS & DRIVERS

Key advantages Over Traditional Methods Drives the Protein Expression Market Growth
Cell-free Protein Synthesis – A Key Tool for Basic and Applied Science
Applications of Cell-Free Protein Synthesis
Cell-free Protein Synthesis in High-Throughput Production
Technological Advancements in Cell Free Protein Extraction Drive Market Prospects
Increased Demand for Cell-Free Protein Expression by Biotechnology Firms
Growth in number of Pharmaceutical Companies Involved in Protein Expression
Pharmaceutical R&D Spending Worldwide (USD Billion): 2015-2025
Increasing Demand from Microbiology for Better Protein Expression to Propel Market Growth
Rising Incidence of Cancer and the Demand for Biologics Spur the Adoption of Cell Free Protein Extraction
Breakdown of Total Number of Cancer Cases by Type: 2020
Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
Rise in New and Advanced applications of Cell Free Protein Expression
Growth in Use of Lysates to Produce Desired Recombinant Proteins Buoys Growth Prospects
Rise in Chronic and Infectious Diseases and Need for High-Throughput Diagnosis Drive Interest in Cell-Free Protein Extraction
Infection Rates of Viruses ((per infected person)) Involved in Outbreaks Worldwide: 2020
Infectious Diseases Related Mortality High Among Children below 5 Years: Breakdown of Leading Causes of Death in Children below 5 Years (in %)
Global Number of Deaths Caused Due to Communicable Diseases (In 000s)
Growing Preference for Personalized Medicine to Drive Market Growth
Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
Rapidly Growing Geriatric Population and the Rise in Associated Diseases Drive the Need for Cell-free Protein Extraction
Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050

A selection of companies mentioned in this report includes

Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
MilliporeSigma
AMS Biotechnology (Europe) Ltd.
Bioneer Corporation
Indivumed GmbH
GeneCopoeia, Inc.
Creative Biolabs
GenScript Biotech Corporation
Cube Biotech GmbH
Jena Bioscience GmbH
biotechrabbit GmbH
CellFree Sciences Co., Ltd.
Creative Biostructure
Global Life Sciences Solutions USA LLC

For more information about this report visit https://www.researchandmarkets.com/r/4t2xtr

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets

Laura Wood, Senior Manager

[email protected]

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/cell-free-protein-expression-market-growth-bolstered-by-rise-in-pharmaceutical-rd-and-personalized-medicine-trend-301976952.html